Primary Effusion Lymphoma (Paperback)


Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. High Quality Content by WIKIPEDIA articles Primary effusion lymphoma (PEL) is a B-cell lymphoma. It is caused by Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8). In most cases, the lymphoma cells are also infected with Epstein Barr virus (EBV). PEL most commonly arises in patients with underlying immunodeficiency, such as AIDS. The condition can exist in the absence of HHV-8 and HIV, though this is rare. PEL is unusual in that the majority of cases arise in body cavities, such as the pleural space or the pericardium; another name for PEL is "body cavity lymphoma." A case has been described that was positive for CD38, CD71 and CD30. It was recognized as a unique type of lymphoma only after the discovery of KSHV in 1994. It is generally resistant to cancer chemotherapy drugs that are active against other lymphomas, and carries a poor prognosis.

R1,048

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles10480
Mobicred@R98pm x 12* Mobicred Info
Free Delivery
Delivery AdviceOut of stock

Toggle WishListAdd to wish list
Review this Item

Product Description

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. High Quality Content by WIKIPEDIA articles Primary effusion lymphoma (PEL) is a B-cell lymphoma. It is caused by Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8). In most cases, the lymphoma cells are also infected with Epstein Barr virus (EBV). PEL most commonly arises in patients with underlying immunodeficiency, such as AIDS. The condition can exist in the absence of HHV-8 and HIV, though this is rare. PEL is unusual in that the majority of cases arise in body cavities, such as the pleural space or the pericardium; another name for PEL is "body cavity lymphoma." A case has been described that was positive for CD38, CD71 and CD30. It was recognized as a unique type of lymphoma only after the discovery of KSHV in 1994. It is generally resistant to cancer chemotherapy drugs that are active against other lymphomas, and carries a poor prognosis.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Betascript Publishing

Country of origin

United States

Release date

October 2010

Availability

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

First published

October 2010

Editors

, ,

Dimensions

229 x 152 x 4mm (L x W x T)

Format

Paperback - Trade

Pages

70

ISBN-13

978-6133295230

Barcode

9786133295230

Categories

LSN

6133295236



Trending On Loot